The management of dogs with chronic hepatitis and cats with lymphocytic plasmacytic cholangitis.
Primary biliary cirrhosis
Chronic inflammatory hepatobiliary disease
UDCA reduces albuminuria and prevent progression of kidney damage.
Immunomodulatory UDCA is believed to involve decreased immunoglobulin production by B lymphocytes, decreased interleukin-1 and -2 production by T lymphocytes, decreased expression of hepatocyte cell surface membrane HA class I molecules and possibly stimulation of the hepatocyte glucocorticoid receptor.
Hepatic Lipidosis & Lepto spirosis
Toxicities from NSAIDS & Hepatic firbrosis
Guards hepatic cells against destruction
Protection of cells from oxidative stress
Works by triggering and increase in the level of glutathione (an oxidant which can help defend the liver from toxins)
Et-Liv UD should be used cautiously in pets that may have complications related to gallstones such as biliary obstruction, cholecystitis, or pancreatitis. Because safety has not been clearly established, ursodiol should be used cautiously in pregnant and lactating pets.
Composition : Each 10 Ml Contains
Milk thistle (Silybum marianum) (Standardised to contain NLT 80% of Silymarin (Silybin A+B))
Ursodiol (Bile Acid)
BCAA’s Blend (2:1:1)
9 / 42
2ml per 5kg per day Or as directed by the veterinarian